Naltrexone Poa Pharma (Naltrexone Hydrochloride)

Naltrexone Hydrochloride, the active ingredient in Naltrexone Poa Pharma, is an opioid antagonist presented as an oral tablet for oral use. It is employed in the management of alcohol dependence and opioid dependence in adult patients. GNH USA supplies Naltrexone Poa Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naltrexone works within the opioid receptor pathway to reduce cravings and prevent relapse in substance‑use disorders. - Alcohol dependence: helps maintain abstinence by blocking rewarding effects of alcohol. - Opioid dependence: supports long‑term recovery by preventing opioid‑induced euphoria after detoxification. - Opioid use disorder relapse prevention: reduces risk of relapse when used as part of a comprehensive treatment program.

Naltrexone may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea: transient gastrointestinal upset often occurring early in therapy. - Headache: mild to moderate intensity, usually resolves with continued use. - Dizziness: may be experienced during dose titration. - Fatigue: general tiredness reported by some patients.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury, requiring monitoring. - Severe depression or suicidal ideation: mood changes that need immediate medical attention. - Allergic reactions: rash, pruritus, or anaphylaxis in rare cases.

Before initiating therapy, clinicians should evaluate patient history and monitor for specific risks. - Assess liver function: obtain baseline hepatic enzymes and monitor periodically. - Monitor for depression: watch for mood changes or suicidal thoughts. - Avoid in acute hepatitis: contraindicated in active severe liver disease. - Use caution with concomitant opioids: may precipitate acute withdrawal. - Store at room temperature: keep in the original pack, protect from moisture.

Naltrexone can interact with several medication classes, requiring careful management.

Major Interactions (Avoid): - Opioid agonists: can trigger sudden opioid withdrawal. - Alcohol: may increase sedation and hepatic strain. - Hepatotoxic drugs: combined use may elevate risk of liver injury.

Moderate Interactions (Monitor Closely): - Benzodiazepines: additive central nervous system depression. - Antidepressants: potential influence on mood and withdrawal symptoms. - CYP3A4 inhibitors: may raise plasma levels of naltrexone.